Companhia Brasileira De Distribuicao (CBD) Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Companhia Brasileira De Distribuicao in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CBD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CBD, but not buy additional shares or sell existing shares.
View CBD analyst ratings or view top-rated stocks.

2 brokers have issued 1 year price targets for Companhia Brasileira De Distribuicao's stock. Their CBD share price forecasts range from $2.80 to $2.80. On average, they expect the company's stock price to reach $2.80 in the next year. This suggests that the stock has a possible downside of 12.2%.
View analysts price targets for CBD or view top-rated stocks among Wall Street analysts.

Companhia Brasileira De Distribuicao's stock was trading at $3.10 at the start of the year. Since then, CBD shares have increased by 2.9% and is now trading at $3.19.
View the best growth stocks for 2023 here.

Companhia Brasileira De Distribuicao saw a drop in short interest in May. As of May 15th, there was short interest totaling 1,750,000 shares, a drop of 21.5% from the April 30th total of 2,230,000 shares. Based on an average daily volume of 1,290,000 shares, the short-interest ratio is presently 1.4 days. Currently, 0.7% of the shares of the stock are sold short.
View Companhia Brasileira De Distribuicao's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 26th 2023.
View our CBD earnings forecast.

Companhia Brasileira De Distribuicao (NYSE:CBD) posted its quarterly earnings data on Tuesday, May, 10th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by $0.10. The company earned $4.56 billion during the quarter. Companhia Brasileira De Distribuicao had a negative trailing twelve-month return on equity of 7.88% and a net margin of 3.70%.

VanEck Brazil Small-Cap ETF holds 96,071 shares of CBD stock, representing 1.11% of its portfolio.

Companhia Brasileira De Distribuicao (NYSE:CBD) pays an annual dividend of $0.06 per share and currently has a dividend yield of 1.84%.
Read our dividend analysis for CBD.

Based on aggregate information from My MarketBeat watchlists, some companies that other Companhia Brasileira De Distribuicao investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Hawkins (HWKN), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), Och-Ziff Capital Management Group (OZM), Gran Tierra Energy (GTE) and Transocean (RIG).

Companhia Brasileira De Distribuicao trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBD."

Companhia Brasileira De Distribuicao's stock is owned by many different institutional and retail investors. Top institutional investors include UBS Group AG (0.45%), BlackRock Inc. (0.44%), JPMorgan Chase & Co. (0.20%), Two Sigma Advisers LP (0.17%), American Century Companies Inc. (0.16%) and Bank of America Corp DE (0.15%).

Shares of CBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CBD stock can currently be purchased for approximately $3.19.

Companhia Brasileira De Distribuicao (NYSE:CBD) has a market capitalization of $859.55 million and generates $3.35 billion in revenue each year.

The company employs 91,917 workers across the globe.

Companhia Brasileira De Distribuicao's mailing address is AVENIDA BRIGADEIRO LUIZ ANTONIO 3142, Sao Paulo D5, 01402. The official website for the company is www.gpari.com.br. The company can be reached via phone at 551138860533, via email at gpa.ri@gpabr.com, or via fax at 55-11-3884-2677.